{
    "clinical_study": {
        "@rank": "70678", 
        "arm_group": [
            {
                "arm_group_label": "duramorph", 
                "arm_group_type": "Active Comparator", 
                "description": "duramorph 150 mcg administered spinally with placebo capsules administered by mouth every 6 hours x 4 doses during first 24 hours"
            }, 
            {
                "arm_group_label": "no duramorph", 
                "arm_group_type": "Experimental", 
                "description": "no duramorph is administered spinally for surgery;  subjects receive acetaminophen 1 G orally x 4 doses during first 24 hours postoperatively"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators are attempting to see if eliminating the amount of long acting spinal\n      narcotic during cesarean section delivery will demonstrate pain scores with movement when\n      evaluated 24 hours postoperatively as those that receive the standard dosage of spinal\n      narcotic when combined with oral acetaminophen or placebo.  The investigators also are\n      evaluating if there are decreased side effects related to decreased narcotic usage."
        }, 
        "brief_title": "Low Pain Prediction in Cesarean Section Patients", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Scheduled Cesarean Sections", 
            "Postoperative Pain Management", 
            "Side Effects"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "Subjects are randomized on the morning of surgery to receive a standard dose of spinal\n      narcotic or to receive no long acting spinal narcotic. The subjects may or may not also\n      receive acetaminophen orally postoperatively.  Pain scores are done on postoperative day one\n      as well as evaluation of potential narcotic side effects such as nausea/vomiting, itching,\n      and sedation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  anticipated pain level estimated to be in the lowest 20th percentile (calculated\n             <34.3 utilizing our standard preoperative questionnaire)\n\n          -  age >/= 18\n\n          -  not allergic to any study medications to be utilized in this study\n\n          -  singleton pregnancy\n\n        Exclusion Criteria:\n\n          -  allergies to morphine or acetaminophen\n\n          -  diagnosis of a chronic pain disorder\n\n          -  weight >300 lbs\n\n          -  hepatic disease"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02143141", 
            "org_study_id": "IRB 17294"
        }, 
        "intervention": [
            {
                "arm_group_label": "duramorph", 
                "description": "duramorph 150 mcg given with spinal anesthetic, then receipt of placebo capsules postoperatively.  evaluation postoperative day 1 for measurement of itching, nausea, vomiting, pain and itching.", 
                "intervention_name": "duramorph", 
                "intervention_type": "Drug", 
                "other_name": "duramorph versus placebo"
            }, 
            {
                "arm_group_label": "no duramorph", 
                "description": "placebo in an equal volume to that of duramorph 150 mcg given with spinal anesthetic, then receipt of oral acetaminophen 1000mg during first 24 hours postoperatively.  evaluation postoperative day 1 for measurement of itching, nausea, vomiting, pain and itching.", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Morphine", 
                "Narcotics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "postoperative pain", 
            "narcotic side effects"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "jbooth@wakehealth.edu", 
                "last_name": "Jessica Booth, MD", 
                "phone": "336-718-8278"
            }, 
            "contact_backup": {
                "email": "lcharris@wakehealth.edu", 
                "last_name": "Lynnette Harris, BSN", 
                "phone": "336-718-6049"
            }, 
            "facility": {
                "address": {
                    "city": "Winston-Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27103"
                }, 
                "name": "Forsyth Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Peter Pan, MD, MSEE", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "James Eisenach, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Eliminating Long Acting Spinal Narcotic Use and Its Associated Side Effects for Those Who do Not Need it After Cesarean Delivery", 
        "overall_contact": {
            "email": "jbooth@wakehealth.edu", 
            "last_name": "Jessica Booth, MD", 
            "phone": "336-7188278"
        }, 
        "overall_contact_backup": {
            "email": "lcharris@wakehealth.edu", 
            "last_name": "Lynnette Harris, BSN", 
            "phone": "336-718-6049"
        }, 
        "overall_official": {
            "affiliation": "Wake Forest School of Medicine", 
            "last_name": "Jessica Booth, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "pain assessment on movement", 
            "measure": "pain", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02143141"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wake Forest School of Medicine", 
            "investigator_full_name": "Dr. Jessica Booth", 
            "investigator_title": "OB Anesthesiologist, Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "itching", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "nausea", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "sedation", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Wake Forest School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wake Forest School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}